Fractional laser and HOF: how they combine

Fractional laser and HOF often meet in the same patient, because the concern "tired skin" is rarely only volume or only texture. But combining technologies is not adding up procedures: it is ordering goals. Laser works on skin quality and texture, while filler, toxin and biostimulator act on volume, expression and support.

This page is a planning overview, at review level. Device parameters, energy and exact intervals belong to the qualified professional, according to the device manual, the products' package inserts and the rules of their professional council in Brazil. For the concept of the device itself, see fractional laser.

What does each technology address?

The first question is which concern belongs to which tool. Mixing this up creates the wrong expectation.

If the patient arrives asking to "remove the marks from the face" and you only offer volumizing, the conversation is about referral, not about selling. If they ask for volume and the skin has deep scars, filler alone does not solve what they see in the mirror.

Why does the interval matter?

Fractional laser creates microzones of controlled injury that trigger healing and remodeling, with participation of the fibroblasts. During that phase the skin shows erythema, swelling, sensitivity and a compromised barrier. Three concerns guide the interval between laser and injectables:

1. Inflammation over freshly injected product. Heat and inflammation over a recently filled area are a concern, which is why many protocols avoid layering thermal technology over product in the first few days. The concrete rule depends on the type of laser and the product.
2. Open or peeling skin. Needles and injectables in skin with active microinjuries increase the risk of infection and of an inflammatory response.
3. Confusing clinical reading. Swelling from the laser and swelling from the filler added together make it hard to tell what is effect, what is response and what is a complication.

In what order is it usually planned?

There are different logics, and all of them should be defended on clinical grounds, not habit.

• Skin first, volume later: when the main concern is texture, some professionals treat the skin first and leave volume for the next stage, once the inflammation has passed.
• Volume first, skin later: when the face has evident volume loss that changes how the skin reads, some prefer to restore support first and only then work on the surface.
• Toxin first: because toxin acts on expression and does not depend on skin integrity in the same way, it is usually placed at its own moment, avoiding overlapping events on the same day.

The common thread is a written plan, with dates and order, that the patient understands and accepts.

This outline is illustrative. Actual timeframes are left to the discretion of the qualified professional.

Who calls for more caution?

Risk assessment comes before any combination. Three groups call for extra attention.

Higher phototypes

Skin with more melanin tends to respond to inflammation by darkening. Post-inflammatory hyperpigmentation is the classic complication of laser in these cases. The Fitzpatrick classification helps record the risk, but does not replace clinical examination. The topic is explored further in HOF in Black skin.

History of herpes, keloid or atypical healing

Herpes can be reactivated by trauma and heat. Hypertrophic scarring and keloid change the decision about the technology. Ask in the medical history, and see medical history in HOF for the list.

Use of isotretinoin and other medications

Current or recent isotretinoin use is one of the most cited reasons for caution in procedures that aggress the skin. The subject is covered in isotretinoin and injectable procedures. Systemic corticosteroids also interfere with healing, as shown in systemic corticosteroids and healing.

How do you explain it to the patient?

The most common mistake is selling the combination as a "rejuvenation package." The patient should understand that these are distinct treatments, with distinct recovery times, that call for patience between stages.

Include in the informed consent the risks of each procedure and the reason for separating the stages. When there is more than one device or product in the plan, describe this in the patient record.

Checklist before combining

How does Harmy fit into this planning?

Harmy does not simulate laser, texture or skin. It simulates the volume part: with one front photo, you mark the areas, set the ml and the intensity, and show the patient what the volume projection would look like. This helps separate, in the conversation, what volume solves from what depends on skin quality.

If the patient expects the projection to "remove the marks," explain that the simulation is illustrative and does not represent laser. The usage flow is in how to use Harmy.

Quick quiz

Points of attention for the office

If you work in a team, with dermatology or another specialty doing the laser, align communication: who did what, on what date, with which device. Patient referral and the patient record are where that alignment takes shape. Each professional answers for what they perform, and the division of responsibilities should be clear to the patient.

Combining fractional laser with HOF makes sense when there is a concern for each tool, an ordered plan and a patient informed about the timeframes. Without that, what looks like synergy turns into stacked inflammation, and the result the patient sees comes down to luck.